Steward Partners Investment Advisory, LLC Halozyme Therapeutics, Inc. Transaction History
Steward Partners Investment Advisory, LLC
- $9.37 Billion
- Q2 2024
A detailed history of Steward Partners Investment Advisory, LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Steward Partners Investment Advisory, LLC holds 313 shares of HALO stock, worth $18,623. This represents 0.0% of its overall portfolio holdings.
Number of Shares
313
Previous 300
4.33%
Holding current value
$18,623
Previous $12,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding HALO
# of Institutions
488Shares Held
122MCall Options Held
208KPut Options Held
66.3K-
Black Rock Inc. New York, NY17.6MShares$1.05 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.9MShares$766 Million0.01% of portfolio
-
State Street Corp Boston, MA5.81MShares$346 Million0.01% of portfolio
-
Snyder Capital Management L P San Francisco, CA4.04MShares$240 Million4.92% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI3.72MShares$221 Million0.31% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $8.29B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...